Novel, potent, and orally bioavailable LSD1 inhibitors induce fetal hemoglobin synthesis in a sickle cell disease mouse model. Wang Y, Yu L, Deng K, Packiarajan M, et al. Blood 2025;146:356-368.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Y, Yu L, Deng K, Packiarajan M, et al. Novel, potent, and orally bioavailable LSD1 inhibitors induce fetal hemoglobin synthesis in a sickle cell disease mouse model. Blood 2025;146:356-368.
PMID: 40332031